Hypertension and medication-related renal dysfunction in the HIV-infected patient

被引:2
作者
Szczech, LA [1 ]
机构
[1] Duke Univ, Med Ctr, Duke Inst Renal Outcomes Res & Hlth Policy, Durham, NC 27710 USA
关键词
D O I
10.1053/snep.2001.23767
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Given the improved life expectancy with highly active antiretroviral therapy among patients with human immunodeficiency virus (HIV)-infection, the treatment of medical problems such as hypertension will become increasingly more important. Although HIV-infected patients are at increased risk for the development of pulmonary hypertension, there is little data to suggest they are at increased risk for systemic hypertension or secondary causes of hypertension. Multiple potential drug interactions exist between antiretroviral medications, particularly the protease inhibitors and antihypertensive medications. Additionally, certain antiretroviral medications have frequent and important side effects relating to the kidneys and urinary system. Knowledge of these interactions and side effects is essential toward caring for the patient with HIV-infection. Copyright © 2001 W.B. Saunders Company.
引用
收藏
页码:386 / 393
页数:8
相关论文
共 51 条
[1]  
AARONS EJ, 1991, AIDS, V5, P1276, DOI 10.1097/00002030-199110000-00029
[2]   Disposition of foscarnet during peritoneal dialysis [J].
Alexander, ACM ;
Akers, A ;
Matzke, GR ;
Aweeka, FT ;
Fraley, DS .
ANNALS OF PHARMACOTHERAPY, 1996, 30 (10) :1106-1109
[3]  
Bach MC, 1997, J ACQ IMMUN DEF SYND, V14, P296
[4]   Acute renal failure due to indinavir crystalluria and nephrolithiasis: Report of two cases [J].
Berns, JS ;
Cohen, RM ;
Silverman, M ;
Turner, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1997, 30 (04) :558-560
[5]   THE CLINICAL SPECTRUM OF RENAL-DISEASE ASSOCIATED WITH HUMAN IMMUNODEFICIENCY VIRUS [J].
BOURGOIGNIE, JJ ;
MENESES, R ;
ORTIZ, C ;
JAFFE, D ;
PARDO, V .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1988, 12 (02) :131-137
[6]  
Burns GC, 1997, J AM SOC NEPHROL, V8, P1140
[7]   Severe hypertension and renal atrophy associated with indinavir [J].
Cattelan, AM ;
Trevenzoli, M ;
Naso, A ;
Meneghetti, F ;
Cadrobbi, P .
CLINICAL INFECTIOUS DISEASES, 2000, 30 (03) :619-621
[8]   CLINICAL PHARMACOKINETICS OF ADEFOVIR IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS [J].
CUNDY, KC ;
BARDITCHCROVO, P ;
WALKER, RE ;
COLLIER, AC ;
EBELING, D ;
TOOLE, J ;
JAFFE, HS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (11) :2401-2405
[9]   LEIOMYOMA OF THE ADRENAL-GLAND IN A PATIENT WITH AIDS [J].
DAHAN, H ;
BEGES, C ;
WEISS, L ;
ABITBOL, M ;
LEDREFF, O ;
TEMAN, G ;
BELATTAR, K ;
RYMER, R .
ABDOMINAL IMAGING, 1994, 19 (03) :259-261
[10]   Urinary stones in HIV-1-positive patients treated with indinavir [J].
Daudon, M ;
Estepa, L ;
Viard, JP ;
Joly, D ;
Jungers, P .
LANCET, 1997, 349 (9061) :1294-1295